semaglutide and mthfr targets MASH molecular pathways beyond weight loss Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

By integrating peptide therapy with other functional medicine modalities, we are able to achieve comprehensive wellness solutions for our patients that go beyond mere symptom management

While the primary endpoint (cerebral glucose metabolism) was not met, these findings suggest injectable GLP-1s may be more effective than oral formulations

The most common are: Gastrointestinal symptoms, including nausea, vomiting, diarrhea, abdominal pain, and constipation

Medical weight loss in Trenton, NJ Trenton patients often choose medical weight loss after years of inconsistent results, busy schedules, or limited access to in-person care